ARTMS

ARTMS is proud to be the only international solid target system with multiple DMFs for medical isotopes. Our commitment to regulatory excellence makes it easier for customers to accelerate adoption and confidently scale production. Innovation. Compliance. Global readiness. Get in touch to find out more info: https://artms.ca/contact/ #ARTMS #QuantmIsotopeProduction #CyclotronProduction #DMF

ARTMS is extremely excited by Telix Pharmaceuticals Limited continued global expansion and commitment in the cyclotron and isotope production space. As the Telix Manufacturing Solutions Yokohama site continues to expand capabilities, ARTMS will be an integral part for isotope production in the region. To learn more, be sure to read Telix’s latest press release: https://bit.ly/48IJOwQ

The 65th Annual Scientific Meeting of the Japanese Society of Nuclear Medicine is underway! It’s inspiring to see so much collaboration and momentum in isotope production and cyclotron technology. If you’re here — come say hello and let’s connect! #JSNM2025 #NuclearMedicine

ARTMS will be joining the Telix Japan team and is proud to be attending the 65th Annual Scientific Meeting of the Japanese Society of Nuclear Medicine this week in Japan! Our own Kevin Reimer is on-site connecting with leaders in nuclear medicine and discussing innovations in isotope production and cyclotron technology. If you’re attending JSNM — let’s connect! #JSNM2025 #NuclearMedicine

In great news for U.S. patients, Telix's Gozellix® has been granted Transitional Pass-Through payment status by the U.S. Centers for Medicare & Medicaid Services (CMS). We’re proud to have supported the development of this next generation product. The approval references our DMF for large-scale gallium production with QIS®. Read the full press release: https://bit.ly/47CCp1l

Thank you to everyone who connected with us at EANM 2025! It was a privilege to meet so many colleagues, partners, and leaders in nuclear medicine. We’re energized by the conversations and excited for what’s ahead. #EANM2025 #ThankYou #ARTMS

We’re on site at EANM 2025 in Barcelona – let’s connect! Say hello to Chad Watkins and Kevin Reimer, who will be representing ARTMS throughout the meeting. We’d love to meet you, answer your questions, and share what’s ahead. #EANM2025 #LetsConnect #ARTMS

We’re excited to announce that ARTMS will be attending EANM 2025 in Barcelona, October 4–8! Join us as we highlight ARTMS innovations and connect with the global nuclear medicine community. #EANM2025 #NuclearMedicine #ARTMS

SNMMI 2025 was a success — and we’re grateful to everyone who stopped by Telix booth #408 and those who connected with the ARTMS team. Couldn’t make it? Watch the video we shared at the event to see how ARTMS is transforming isotope production and driving innovation across nuclear medicine. Thanks again for the great conversations — let’s keep them going!

Day 1 at SNMMI 2025 and we’re just getting started! ARTMS is live at the meeting — connecting, sharing, and showcasing our mission. Stop by Telix booth #408 to catch up with our team and see our new video in action. Say hello to Chad Watkins, Kevin Reimer, and Joel Kumlin — we’d love to connect